Valneva SE

Valneva SE is a specialty vaccine company registered in Saint-Herblain, France, developing, producing and commercializing vaccines for infectious diseases. It has manufacturing sites in Livingston, Scotland; Solna, Sweden, and Vienna, Austria; with other offices in France, Canada and the United States.

Filings

12 filings

All Inside information94 Voting rights and capital38 Earnings release12 Threshold crossing5 Quarterly financial information4 Half-year financial report3 Universal registration document2 Annual financial report2

22/07/2026
Valneva to Report First Half 2026 Consolidated Financial Results on August 13, 2026
Earnings releaseFR
06/05/2026
Valneva to Report First Quarter 2026 Consolidated Financial Results on May 13, 2026
Earnings releaseFR
05/05/2026
Valneva to Report First Quarter 2026 Consolidated Financial Results on May 13, 2026
Earnings releaseFR
18/03/2026
Valneva Reports Full Year 2025 Audited Consolidated Financial Results
Earnings releaseFR
09/03/2026
Valneva to Report Full Year 2025 Consolidated Financial Results on March 18, 2026
Earnings release
19/02/2026
Valneva publie son chiffre d’affaires et sa trésorerie non audités pour l’exercice 2025 et fournit ses prévisions pour l’exercice 2026
Earnings releaseFrench
20/03/2025
Valneva Reports Full Year 2024 Results and Provides Business Updates and Outlook
Earnings release
18/02/2025
Valneva publie son chiffre d’affaires et sa trésorerie non audités pour l’exercice 2024 et fournit des indications préliminaires pour l’exercice 2025
Earnings releaseFrench

About

ISIN: FR0004056851
Ticker: VLA
LEI: 969500DIVIP5VKNW4948
Sector: Health care
Founded: 1999
Country of registration: FR
Last filing: 22/07/2026, 17:45

Wikipedia

Description from Wikidata, CC0 licence.

Filing history

Filings per month

Sept 23May 24Jan 25Sept 25Aug 26

Document types

Across the whole archive